scispace - formally typeset
G

Giovanni N. Roviello

Researcher at National Research Council

Publications -  117
Citations -  2413

Giovanni N. Roviello is an academic researcher from National Research Council. The author has contributed to research in topics: Nucleic acid & Medicine. The author has an hindex of 23, co-authored 92 publications receiving 1633 citations. Previous affiliations of Giovanni N. Roviello include University of Göttingen.

Papers
More filters
Journal ArticleDOI

An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies

TL;DR: Various approaches recently proposed in the literature to inhibit HMGB1 and the related inflammatory processes are described, especially focusing on the block of RAGE-HMGB1 signaling.
Journal ArticleDOI

SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.

TL;DR: Since the recoveries/deaths ratio in the last weeks significantly increased, especially in China, it is clear that the experimental antiviral therapy, together with the availability of intensive care unit beds in hospitals and rigorous government control measures, all play an important role in dealing with this virus.
Journal ArticleDOI

G-quadruplex-based aptamers against protein targets in therapy and diagnostics

TL;DR: Recent advancements in SELEX technology for the efficient and rapid identification of new candidate aptamers (introduction of microfluidic systems and next generation sequencing) and discovery of several G4-forming motifs in important regulatory regions of the human or viral genome bound by endogenous proteins are reviewed.
Journal ArticleDOI

Lower COVID-19 mortality in Italian forested areas suggests immunoprotection by Mediterranean plants.

TL;DR: It is suggested that evergreen Mediterranean forests and shrubland plants could have protected the southern population by emission of immuno-modulating VOCs and provision of dietary sources of bioactive compounds.
Journal ArticleDOI

Molecular Basis of the Therapeutical Potential of Clove ( Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility.

TL;DR: In this paper, the potential role of clove in the frame of anti-COVID-19 therapy, focusing on the antiviral, anti-inflammatory, and antithrombotic effects of Clove and its molecular constituents described in the scientific literature.